Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Vanguard Investments Canada Announces Estimated 2023 Annual Capital Gains Distributions for the Vanguard ETFs®
-
PSB Holdings, Inc. announces semi-annual cash dividend of $0.30 per share
-
Tidewater Presents Charity Outing Proceeds to Food Bank of Delaware
-
The Chicago School President Michele Nealon Addresses Holiday Blues and Offers Tips for Improving Mental Health During This Holiday Season
-
Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders
-
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
-
Kering: Monthly statement on the total number of shares and voting rights (December 2023)
-
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint
-
Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway
-
CAPREIT Announces $101MM in New Strategic Transactions
-
AutoZone Authorizes Additional Stock Repurchase
-
European Residential Real Estate Investment Trust Announces Conclusion of Strategic Review Process
-
Rogers Communications 4Q23 Investment Community Teleconference February 1, 2024 at 8:00 a.m. ET
-
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
-
JO/GA Homes Unveils a Miami Beach Sanctuary That Redefines Luxury and Sustainability Standards
-
Park Hotels & Resorts Update on Recent Operating Trends and Capital Allocation Highlights
-
Mawson Infrastructure Group Inc. Announces Monthly Operational Update for November 2023
-
Schuff Steel Company Successfully Resolves EEOC Lawsuit
-
CVB Financial Corp. Announces 137th Consecutive Quarterly Cash Dividend
-
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
-
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
-
ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
-
Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board
-
Coherent Issues Its ESG Report 2023 and Sets a Net Zero Greenhouse Gas Emissions Target of FY2040
-
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Hexagon Purus ASA – Capital raise successfully completed
-
CNH Industrial: Periodic Report on $1 Billion Buyback Program
-
Fluence Stands by its Work on the Diablo Plant, and Will Vigorously Pursue the Payments it is Owed for its Work and Dispute the Allegations in the Counterclaim Filed by the Operator of the Plant
-
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
-
CTO Realty Growth Announces Sale of Single Tenant Office Property in Tampa, FL For $22.0 Million
-
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
-
Shapeways Holdings, Inc. Announces Reductions in Force and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Renexxion Ireland has Completed a Successful Pre-IND Consultation with the United States FDA for Development of Naronapride for Patients with PPI-non-responsive Symptomatic GERD
-
Lowey Dannenberg, P.C. is Investigating BlackRock Inc. (“BlackRock”) (NYSE: BLK) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $100,000 in Losses
-
ADT Announces Departure of Ken Porpora, Chief Financial Officer
-
Forward Reports Preliminary Fiscal 2023 Results: Record Revenues for Design Division Drive Profitability From Continuing Operations
-
Hub Group Expands Its Final Mile Service Offering through the Acquisition of Forward Air Final Mile
-
Southern States Bancshares, Inc. Announces Renewal of $10.0 Million Stock Repurchase Program
-
Dave & Buster’s Announces the Retirement of Michael Quartieri, Chief Financial Officer
-
Actelis Networks Announces Closing of $1.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
-
Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2024
-
Five Below, Inc. Announces Participation in the 2024 ICR Conference
-
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
-
Canacol Energy Ltd. Provides Gas Sales and Drilling Update and Announces Dividend
-
Inventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program
-
Locus Technologies Leads Industry in Safeguarding Customer Data with Renewal of SOC 1 and 2 Examinations
-
C&F Financial Corporation Reauthorizes Share Repurchase Program
-
Blood Community Unites to Recognize Donors Ahead of National Blood Donor Month in January
